Back to search

Article

COVID-19 First and Delta Waves in Relation to ACEI, ARB, Influenza Vaccination, and Comorbidity in a North Metropolitan Barcelona Health Consortium

2022-03-02

Abstract excerpt

BACKGROUND Some authors have reported that angiotensin converter enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) improve clinical outcomes in hypertensive COVID-19 patients, and others have proposed cross-protection for influenza vaccination. The impact of these variables on the evolution of hospitalized patients, focusing in the first wave and the Delta wave, is explored. METHODS COVID-19 hospi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a535cac2-4769-5b29-9ef9-56334a7bf9da
DOI
10.21203/rs.3.rs-1272080/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19 First and Delta Waves in Relation to ACEI, ARB, Influenza Vaccination, and Comorbidity in a North Metropolitan Barcelona Health ConsortiumDOI 10.21203/rs.3.rs-1272080/v1
Select a neighboring publication to make it the new centre.